The federal contract IDV award SPE2DP18D0006 is a single-award indefinite delivery contract issued by the U.S. Department of Defense (DoD) Medical Supply Chain to the pharmaceutical company Glaxosmithkline, LLC. The contract, valued at a ceiling of $27,848,725.95, enables the DoD to order influenza virus vaccines and other pharmaceutical products from Glaxosmithkline, a foreign-owned for-profit organization, over the term of the agreement. Task orders issued under the IDV provide for the firm...
The Defense Logistics Agency Troop Support Medical awarded an Indefinite Delivery Contract to Glaxosmithkline, LLC with a potential value of $50,705,424.00 to supply influenza virus vaccines. Under this contract, three firm fixed price delivery orders were issued for a total of $33,803,616.00 to provide vaccines from Glaxosmithkline's facility in Research Triangle Park, North Carolina. The periods of performance for the delivery orders range from August 31, 2022 through February 24, 2023. The...
This federal contract IDV award, SPE2DP25D0004, is a single-award Indefinite Delivery Contract valued at $6,857,675.50 and administered by the Defense Logistics Agency (DLA) Troop Support. The contract was awarded to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The contract aims to procure injectable, egg-free influenza vaccines for the 2025-2026 flu season, with an estimated annual quantity of 280,000 doses and a maximum of 150% of the annual estimate. The...
The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Glaxosmithkline, LLC to supply influenza virus vaccinations. Delivery orders issued against this vehicle total over $44.5 million and require Glaxosmithkline to provide vaccines from its Research Triangle Park, North Carolina facility. Performance periods range from March 2021 to November 2021. No set-asides or subcontractors are specified. This contract aims to ensure U.S. armed forces and DLA...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The contract, valued at $36,120,112.50, aims to procure approximately 3.23 million doses of injectable influenza virus vaccines in multi-dose vials and pre-filled syringes for various age groups, including elderly, adult, and pediatric populations. The vaccines are intended...
The federal contract IDV award is for the procurement of pediatric flu vaccines by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian agency. The prime contractor is Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company that specializes in vaccines, antiviral medications, and other medical countermeasures. The contract has a ceiling value of $182,592,000.00 and a period of performance from December 31, 2024 to February 28, 2026. It is a multiple award,...
This IDV contract, awarded by the Defense Logistics Agency Troop Support, is for the supply of approximately 3.35 million doses of injectable influenza vaccine for the 2025-2026 flu season. The contract is a single-award indefinite quantity vehicle with a ceiling value of $25,058,634.80 and a period of performance through February 13, 2026. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The...
The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery contract to Seqirus USA Inc. for the supply of injectable influenza virus vaccines. The potential value of the contract vehicle is $22.6 million to be delivered between February 2021 through February 2022. Several firm fixed price delivery orders were subsequently issued against this contract for vaccine quantities between $778 to $6.6 million to support the Agency's medical countermeasures programs....
The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Seqirus USA Inc. to supply influenza virus vaccines. Under this contract vehicle, multiple firm fixed price delivery orders were issued for vaccine doses valued between $13,975 to over $12 million each. Places of performance are Seqirus' Summit, New Jersey facility. Periods of performance span from March 2023 through October 2023. The original solicitation sought proposals to supply approximately 3.39...
The federal contract IDV award to Sanofi Pasteur Inc. is for the provision of influenza virus vaccines and related medical supplies to support various U.S. government agencies, including the Department of Veterans Affairs, Indian Health Service, Centers for Disease Control and Prevention, Defense Logistics Agency, Department of Health and Human Services, Department of Justice Bureau of Prisons, Smithsonian Institution, and Department of State. The 5-year single-award IDV, valued at up to...